Olof Medical Limited 12348904 false 2025-01-01 2025-12-31 2025-12-31 The principal activity of the company is that of specialist medical activities. Digita Accounts Production Advanced 6.30.9574.0 true 12348904 2025-01-01 2025-12-31 12348904 2025-12-31 12348904 bus:Director1 1 2025-12-31 12348904 bus:OrdinaryShareClass1 2025-12-31 12348904 bus:OrdinaryShareClass2 2025-12-31 12348904 bus:OrdinaryShareClass3 2025-12-31 12348904 bus:OrdinaryShareClass4 2025-12-31 12348904 core:RetainedEarningsAccumulatedLosses 2025-12-31 12348904 core:ShareCapital 2025-12-31 12348904 core:FinancialAssetsDesignatedFairValueThroughProfitOrLoss core:CurrentFinancialInstruments 2025-12-31 12348904 core:CurrentFinancialInstruments 2025-12-31 12348904 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 12348904 core:OfficeEquipment 2025-12-31 12348904 bus:SmallEntities 2025-01-01 2025-12-31 12348904 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 12348904 bus:FilletedAccounts 2025-01-01 2025-12-31 12348904 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 12348904 bus:RegisteredOffice 2025-01-01 2025-12-31 12348904 bus:Director1 2025-01-01 2025-12-31 12348904 bus:Director1 1 2025-01-01 2025-12-31 12348904 bus:Director2 2025-01-01 2025-12-31 12348904 bus:OrdinaryShareClass1 2025-01-01 2025-12-31 12348904 bus:OrdinaryShareClass2 2025-01-01 2025-12-31 12348904 bus:OrdinaryShareClass3 2025-01-01 2025-12-31 12348904 bus:OrdinaryShareClass4 2025-01-01 2025-12-31 12348904 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 12348904 bus:Agent1 2025-01-01 2025-12-31 12348904 core:OfficeEquipment 2025-01-01 2025-12-31 12348904 countries:England 2025-01-01 2025-12-31 12348904 2024-12-31 12348904 bus:Director1 1 2024-12-31 12348904 core:OfficeEquipment 2024-12-31 12348904 2024-01-01 2024-12-31 12348904 2024-12-31 12348904 bus:Director1 1 2024-12-31 12348904 bus:OrdinaryShareClass1 2024-12-31 12348904 bus:OrdinaryShareClass2 2024-12-31 12348904 bus:OrdinaryShareClass3 2024-12-31 12348904 bus:OrdinaryShareClass4 2024-12-31 12348904 core:RetainedEarningsAccumulatedLosses 2024-12-31 12348904 core:ShareCapital 2024-12-31 12348904 core:CurrentFinancialInstruments 2024-12-31 12348904 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 12348904 core:OfficeEquipment 2024-12-31 12348904 bus:Director1 2024-01-01 2024-12-31 12348904 bus:Director1 1 2024-01-01 2024-12-31 12348904 bus:Director1 1 2023-12-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 12348904

Olof Medical Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 December 2025

 

Olof Medical Limited

Contents

Company Information

1

Accountants' Report

2

Balance Sheet

3 to 4

Notes to the Unaudited Financial Statements

5 to 10

 

Olof Medical Limited

Company Information

Directors

Dr Max Hookway

Mrs Carla Louise Hookway

Registered office

Wellesley House
204 London Road
Waterlooville
Hampshire
England
PO7 7AN

Accountants

MMO Limited Wellesley House
204 London Road
Waterlooville
Hampshire
PO7 7AN

 

Chartered Accountants' Report to the Board of Directors on the Preparation of the Unaudited Statutory Accounts of
Olof Medical Limited
for the Year Ended 31 December 2025

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Olof Medical Limited for the year ended 31 December 2025 as set out on pages 3 to 10 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at
http://www.icaew.com/regulation.

This report is made solely to the Board of Directors of Olof Medical Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of Olof Medical Limited and state those matters that we have agreed to state to the Board of Directors of Olof Medical Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Olof Medical Limited and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Olof Medical Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Olof Medical Limited. You consider that Olof Medical Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of Olof Medical Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................

MMO Limited
Wellesley House
204 London Road
Waterlooville
Hampshire
PO7 7AN

22 September 2026

 

Olof Medical Limited

(Registration number: 12348904)
Balance Sheet as at 31 December 2025

Note

2025
£

2024
£

Fixed assets

 

Tangible assets

4

6,367

2,462

Current assets

 

Debtors

6

3,929

21,495

Other financial assets

5

100,138

-

Cash at bank and in hand

 

73,964

139,547

 

178,031

161,042

Creditors: Amounts falling due within one year

7

(12,237)

(14,942)

Net current assets

 

165,794

146,100

Total assets less current liabilities

 

172,161

148,562

Provisions for liabilities

(1,210)

(468)

Net assets

 

170,951

148,094

Capital and reserves

 

Called up share capital

8

140

130

Retained earnings

170,811

147,964

Shareholders' funds

 

170,951

148,094

For the financial year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

•

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 22 September 2026 and signed on its behalf by:
 

 

Olof Medical Limited

(Registration number: 12348904)
Balance Sheet as at 31 December 2025

.........................................
Dr Max Hookway
Director

 

Olof Medical Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Wellesley House
204 London Road
Waterlooville
Hampshire
PO7 7AN
England

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

All figures are presented in British Sterling, which is the functional currency of the company, and are rounded to the nearest £1.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

 

Olof Medical Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Office equipment

25% - written down value

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

 

Olof Medical Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2024 - 2).

 

Olof Medical Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

4

Tangible assets

Office equipment
£

Total
£

Cost or valuation

At 1 January 2025

4,882

4,882

Additions

6,027

6,027

At 31 December 2025

10,909

10,909

Depreciation

At 1 January 2025

2,420

2,420

Charge for the year

2,122

2,122

At 31 December 2025

4,542

4,542

Carrying amount

At 31 December 2025

6,367

6,367

At 31 December 2024

2,462

2,462

5

Other financial assets (current and non-current)

Financial assets at fair value through profit and loss
£

Total
£

Current financial assets

Cost or valuation

Additions

100,138

100,138

At 31 December 2025

100,138

100,138

Impairment

Carrying amount

At 31 December 2025

100,138

100,138

 

Olof Medical Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

6

Debtors

Current

2025
£

2024
£

Trade debtors

3,848

4,541

Prepayments

-

3,105

Other debtors

81

13,849

 

3,929

21,495

7

Creditors

Creditors: amounts falling due within one year

2025
£

2024
£

Due within one year

Taxation and social security

6,384

8,478

Accruals and deferred income

1,800

1,800

Other creditors

4,053

4,664

12,237

14,942

8

Share capital

Allotted, called up and fully paid shares

2025

2024

No.

£

No.

£

Ordinary shares of £1 each

100

100

100

100

Ordinary A shares of £1 each

10

10

10

10

Ordinary B shares of £1 each

10

10

10

10

Ordinary C shares of £1 each

10

10

10

10

130

130

130

130

 

Olof Medical Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

9

Related party transactions

Transactions with directors

2025

At 1 January 2025
£

Other payments made to company by director
£

At 31 December 2025
£

Dr Max Hookway

The directors loan account balance is undated, unsecured, interest free and repayable on demand.

8,624

(8,841)

(216)

2024

At 1 January 2024
£

Other payments made to company by director
£

At 31 December 2024
£

Dr Max Hookway

The directors loan account balance is undated, unsecured, interest free and repayable on demand.

1,204

7,420

8,624